| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42308510P | 2010-12-14 | 2010-12-14 |
| Publication Number | Publication Date |
|---|---|
| SG10201510111PAtrue SG10201510111PA (en) | 2016-01-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013045745ASG191155A1 (en) | 2010-12-14 | 2011-12-14 | Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
| SG10201510111PASG10201510111PA (en) | 2010-12-14 | 2011-12-14 | Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013045745ASG191155A1 (en) | 2010-12-14 | 2011-12-14 | Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
| Country | Link |
|---|---|
| US (2) | US9376486B2 (en) |
| EP (1) | EP2651975B1 (en) |
| JP (2) | JP6483337B2 (en) |
| KR (2) | KR101781546B1 (en) |
| CN (1) | CN103534270B (en) |
| AU (2) | AU2011341744B2 (en) |
| BR (1) | BR112013015129B1 (en) |
| CA (1) | CA2821268C (en) |
| CO (1) | CO6801636A2 (en) |
| CY (1) | CY1119854T1 (en) |
| DK (1) | DK2651975T3 (en) |
| EA (1) | EA201390874A1 (en) |
| ES (1) | ES2644236T3 (en) |
| HR (1) | HRP20171580T1 (en) |
| HU (1) | HUE035609T2 (en) |
| IL (1) | IL226957B (en) |
| LT (1) | LT2651975T (en) |
| MX (1) | MX348152B (en) |
| MY (2) | MY201732A (en) |
| PH (2) | PH12013501242B1 (en) |
| PL (1) | PL2651975T3 (en) |
| PT (1) | PT2651975T (en) |
| RS (1) | RS56737B1 (en) |
| SG (2) | SG191155A1 (en) |
| SI (1) | SI2651975T1 (en) |
| SM (1) | SMT201700477T1 (en) |
| WO (1) | WO2012082073A1 (en) |
| ZA (1) | ZA201304459B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2566957T3 (en) | 2007-09-26 | 2016-04-18 | Chugai Seiyaku Kabushiki Kaisha | Constant region of modified antibody |
| BR112013015129B1 (en)* | 2010-12-14 | 2022-11-16 | National University Of Singapore | ISOLATED ANTIBODY OR FRAGMENT THEREOF AND PHARMACEUTICAL COMPOSITION |
| US9821050B2 (en) | 2012-04-02 | 2017-11-21 | The University Of North Carolina At Chapel Hill | Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions |
| WO2014064707A1 (en)* | 2012-10-26 | 2014-05-01 | International Centre For Genetic Engineering And Biotechnology | Pichia pastoris -expressed dengue virus like particles |
| BR112015032388A8 (en)* | 2013-06-26 | 2020-01-14 | Univ North Carolina Chapel Hill | glycoprotein and chimeric dengue virus, their uses, flavivirus particle, isolated nucleic acid molecule, and compositions |
| SG11201606624WA (en) | 2014-02-11 | 2016-09-29 | Visterra Inc | Antibody moleules to dengue virus and uses thereof |
| TWI844507B (en) | 2015-02-05 | 2024-06-11 | 日商中外製藥股份有限公司 | Antibodies comprising an ion concentration dependent antigen-binding domain, fc region variants, and uses therof |
| EP3433274A1 (en) | 2016-03-25 | 2019-01-30 | Visterra, Inc. | Formulation of antibody molecules to dengue virus |
| US11053308B2 (en) | 2016-08-05 | 2021-07-06 | Chugai Seiyaku Kabushiki Kaisha | Method for treating IL-8-related diseases |
| SG10201607778XA (en) | 2016-09-16 | 2018-04-27 | Chugai Pharmaceutical Co Ltd | Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use |
| CN116327926A (en) | 2018-03-15 | 2023-06-27 | 中外制药株式会社 | Anti-dengue virus antibodies with cross-reactivity to Zika virus and methods of use |
| US10526398B2 (en)* | 2018-06-12 | 2020-01-07 | National Defense Medical Center | Anti-dengue virus antibodies and applications thereof |
| WO2020033491A1 (en)* | 2018-08-07 | 2020-02-13 | Chan Zuckerberg Biohub, Inc. | Antibodies against dengue virus and related methods |
| WO2021102363A1 (en)* | 2019-11-20 | 2021-05-27 | The University Of North Carolina At Chapel Hill | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development |
| WO2021127017A1 (en)* | 2019-12-16 | 2021-06-24 | La Jolla Institute For Immunology | Combinations of flavivirus proteins, peptide sequences, epitopes, and methods and uses thereof |
| WO2022162009A1 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Method for rapid identification of cross-reactive and/or rare antibodies |
| WO2022161597A1 (en)* | 2021-01-26 | 2022-08-04 | Eth Zurich | Method for rapid identification of cross-reactive and/or rare antibodies |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| DE3223885A1 (en) | 1982-06-26 | 1983-12-29 | Basf Ag, 6700 Ludwigshafen | MACROPOROISE, HYDROPHILE CARRIER FOR ENZYME |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5714166A (en) | 1986-08-18 | 1998-02-03 | The Dow Chemical Company | Bioactive and/or targeted dendrimer conjugates |
| US5651991A (en) | 1987-10-28 | 1997-07-29 | Nippon Shinyaku Co. Ltd. | Drug carriers |
| US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5314995A (en) | 1990-01-22 | 1994-05-24 | Oncogen | Therapeutic interleukin-2-antibody based fusion proteins |
| KR940003548U (en) | 1992-08-14 | 1994-02-21 | 김형술 | Laundry dryer |
| CA2134348C (en) | 1993-02-26 | 2007-01-02 | Hideo Nogusa | Polysaccharide derivatives and drug carriers |
| US5922545A (en) | 1993-10-29 | 1999-07-13 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| US5786387A (en) | 1994-03-23 | 1998-07-28 | Meiji Seika Kabushiki Kaisha | Lipid double-chain derivative containing polyoxyethylene |
| JP3699141B2 (en) | 1994-09-24 | 2005-09-28 | 伸彦 由井 | Biomolecular assembly of biodegradable pharmaceutical polymer having supramolecular structure and preparation method thereof |
| US5490840A (en) | 1994-09-26 | 1996-02-13 | General Electric Company | Targeted thermal release of drug-polymer conjugates |
| DE4440337A1 (en) | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmaceutical nanosuspensions for drug application as systems with increased saturation solubility and dissolution rate |
| US6071890A (en) | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| US5739277A (en) | 1995-04-14 | 1998-04-14 | Genentech Inc. | Altered polypeptides with increased half-life |
| US6106866A (en) | 1995-07-31 | 2000-08-22 | Access Pharmaceuticals, Inc. | In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites |
| CA2217134A1 (en) | 1996-10-09 | 1998-04-09 | Sumitomo Pharmaceuticals Co., Ltd. | Sustained release formulation |
| HRP20010551B1 (en) | 1998-12-23 | 2013-05-31 | Pfizer Inc. | Human monoclonal antibodies to ctla-4 |
| KR20020047132A (en) | 1999-08-24 | 2002-06-21 | 메다렉스, 인코포레이티드 | Human ctla-4 antibodies and their uses |
| US20040126829A1 (en) | 2001-12-18 | 2004-07-01 | Hildebrand William H. | Anti-HLA assay and methods |
| KR100708398B1 (en) | 2002-03-22 | 2007-04-18 | (주) 에이프로젠 | Humanized antibody and process for preparing same |
| CA2894300A1 (en) | 2003-12-08 | 2005-06-23 | The Government Of The United States Of America, As Represented By The Secreatary, Department Of Health And Human Services | Monoclonal antibodies that bind or neutralize dengue virus |
| TWI445547B (en) | 2007-06-08 | 2014-07-21 | Nat Health Research Institutes | Dengue virus peptide vaccine and methods of preparing and using the same |
| GB0724065D0 (en) | 2007-12-10 | 2008-01-16 | Sparrow Paul A | A spirit level |
| EP2294192A4 (en) | 2008-06-09 | 2011-11-23 | Jolla Inst Allergy Immunolog | COMPOSITIONS AND METHODS FOR TREATMENT AND VACCINATION AGAINST DENGUE VIRUS (VD) |
| MX2011003588A (en) | 2008-10-13 | 2011-10-14 | Inst Research In Biomedicine | Dengue virus neutralizing antibodies and uses thereof. |
| SG173482A1 (en)* | 2009-02-10 | 2011-09-29 | Univ Nanyang Tech | Antibodies for diagnosis and treatment of flaviviral infections |
| BR112013015129B1 (en)* | 2010-12-14 | 2022-11-16 | National University Of Singapore | ISOLATED ANTIBODY OR FRAGMENT THEREOF AND PHARMACEUTICAL COMPOSITION |
| Publication | Publication Date | Title |
|---|---|---|
| ZA201304459B (en) | Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof | |
| IL252154A0 (en) | Antibodies against dr5, preparations containing them and their uses | |
| EP2501724A4 (en) | Monoclonal antibodies and diagnostic uses thereof | |
| IL200610A0 (en) | Human monoclonal anti-ip-10 antibodies and uses thereof | |
| DK2624866T3 (en) | TUMOR-SPECIFIC ANTIBODIES AND USES THEREOF | |
| DK2222706T3 (en) | ANTIBODIES AGAINST HUMAN NKG2D AND USES THEREOF | |
| IL222270A (en) | Monoclonal antibody or fragment thereof which binds full length human lif, pharmaceutical composition comprising the same and process for its preparation | |
| IL207129A0 (en) | Ron antibodies and uses thereof | |
| RS62700B1 (en) | Anti-cd277 antibodies and uses thereof | |
| EP2471814A4 (en) | Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody | |
| EP2567982A4 (en) | ANTIBODIES AGAINST CARCINOEMBRYONAL ANTIGEN AND USES THEREOF | |
| AP2010005249A0 (en) | New antibodies specific of the B-amyloid peptides and their uses as diagnostic agents or drugs | |
| HRP20181811T1 (en) | COLLECTION OF THE ANTIBODIES AND ITS USES | |
| EP2318438A4 (en) | ANTI-P2X7 PEPTIDES AND EPITOPES | |
| DK2623592T3 (en) | ANTI-HUMAN CCR7 ANTIBODIES, HYBRIDOM, MEDICAL COMPOSITION AND ANTIBODY IMMOBILIZED CARRIER | |
| LT2493930T (en) | Improved anti human Fraktalkine antibodies and uses thereof | |
| EP2797629A4 (en) | Aglycosylated human antibody and fusion protein and uses thereof | |
| LT3173427T (en) | ANTIBODIES AGAINST INCINS-RELATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS | |
| EP2528939A4 (en) | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same | |
| EP2412721A4 (en) | KOI HERPESVIRUS SPECIFIC ANTIBODY AND ANTIGEN THEREOF | |
| ZA201103941B (en) | Anti-ferroportin 1 monoclonal antibodies and uses thereof | |
| EP2322610A4 (en) | Anti-human clcp1 antibody and use thereof | |
| EP2546269A4 (en) | PRDX4 NECROSE ANTI-MARKER MONOCLONAL ANTIBODY AND USES THEREOF | |
| EP2659273A4 (en) | Monoclonal antibodies against alpha-actinin-4 antigens, and uses therefor | |
| IL212945B (en) | wdrpuh epitope peptides and vaccines containing them |